{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:05:25Z","timestamp":1785150325996,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["08\/1369(25265)\/2025-EMR-I"],"award-info":[{"award-number":["08\/1369(25265)\/2025-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EEQ\/2021\/000955"],"award-info":[{"award-number":["EEQ\/2021\/000955"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejphar.2026.178916","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:32:47Z","timestamp":1777617167000},"page":"178916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Agmatine interaction with imidazoline receptor inhibits manifestation of depression-like behavior in 3-Nitropropionic acid-induced Huntington's disease-like phenotype in rats"],"prefix":"10.1016","volume":"1025","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2150-5118","authenticated-orcid":false,"given":"Raj","family":"Katariya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Jari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4596-192X","authenticated-orcid":false,"given":"Poonam","family":"Dhaigude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4438-1359","authenticated-orcid":false,"given":"Amol","family":"Pable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandkishor","family":"Kotagale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejphar.2026.178916_bib1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/biom12081023","article-title":"Anti-Huntington\u2019s effect of Rosiridin via oxidative stress\/ache Inhibition and modulation of succinate dehydrogenase, nitrite, and BDNF levels against 3-Nitropropionic acid in rodents","volume":"12","author":"Afzal","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178916_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/fcp.12034","article-title":"Participation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in rats","volume":"28","author":"Aglawe","year":"2014","journal-title":"Fund. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178916_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1556\/AChrom.27.2015.3.2","article-title":"Development and validation of a specific RP-HPLC method for the estimation of \u03b3-aminobutyric acid in rat brain tissue samples using benzoyl chloride derivatization and PDA detection","volume":"27","author":"Akula","year":"2015","journal-title":"Acta Chromatogr."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178916_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jjp.69.285","article-title":"Selective inhibition of inducible nitric oxide synthase by agmatine","volume":"69","author":"Auguet","year":"1995","journal-title":"Jpn. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178916_bib5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11064-018-02712-1","article-title":"Therapeutic effect of agmatine on neurological disease: focus on ion channels and receptors","volume":"44","author":"Barua","year":"2019","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178916_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-3057(02)01079-1","article-title":"An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine","volume":"74","author":"Bence","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"13","key":"10.1016\/j.ejphar.2026.178916_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310809","article-title":"Unraveling molecular and genetic insights into neurodegenerative diseases: advances in understanding Alzheimer's, Parkinson's, and Huntington's diseases and amyotrophic lateral sclerosis","volume":"24","author":"Ciurea","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178916_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbr.2016.06.014","article-title":"Agmatine attenuates reserpine-induced oral dyskinesia in mice: role of oxidative stress, nitric oxide and glutamate NMDA receptors","volume":"312","author":"Cunha","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2026.178916_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.biopha.2018.06.079","article-title":"Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats","volume":"105","author":"Danduga","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178916_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1590\/1516-4446-2015-1834","article-title":"Electroencephalographic findings in patients with major depressive disorder during cognitive or emotional tasks: a systematic review","volume":"38","author":"De Freitas","year":"2016","journal-title":"Brazilian Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178916_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/jnsbm.JNSBM_239_17","article-title":"Neuroprotective effect of agmatine in mouse spinal cord injury model: modulation by imidazoline receptors","volume":"9","author":"Dixit","year":"2018","journal-title":"J. Nat. Sci. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.178916_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.02.045","article-title":"Imidazoline binding sites mediates anticompulsive-like effect of agmatine in marble-burying behavior in mice","volume":"732","author":"Dixit","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.ejphar.2026.178916_bib13","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1096\/fasebj.13.15.2125","article-title":"Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP","volume":"13","author":"Galea","year":"1999","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178916_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtcme.2022.06.001","article-title":"Achyranthes aspera ameliorates stress induced depression in mice by regulating neuroinflammatory cytokines","volume":"12","author":"Gawande","year":"2022","journal-title":"J. Tradit. Complement. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2026.178916_bib15","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/acn3.52120","article-title":"Modifiable factors associated with huntington's disease progression in presymptomatic participants","volume":"11","author":"Gil\u2010Salcedo","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178916_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s11033-025-10852-1","article-title":"Evidence based molecular pathways, available drug targets, pre-clinical animal models and future disease modifying treatments of huntington's disease","volume":"52","author":"Goel","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178916_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1163\/22134468-00002072","article-title":"Bayesian optimization of interval timing and biases in temporal memory as a function of temporal context, feedback, and dopamine levels in young, aged and Parkinson's disease patients","volume":"4","author":"Gu","year":"2016","journal-title":"Timing & Time Percept."},{"key":"10.1016\/j.ejphar.2026.178916_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresbull.2014.02.007","article-title":"Pharmacological benefit of I1-imidazoline receptors activation and nuclear factor kappa-B (NF-\u03baB) modulation in experimental huntington's disease","volume":"102","author":"Gupta","year":"2014","journal-title":"Brain Res. Bull."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178916_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine: metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.ejphar.2026.178916_bib20","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s10787-022-01004-z","article-title":"Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: emphasis on Sirt1\/Nrf2 signaling pathway","volume":"30","author":"Ibrahim","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"11","key":"10.1016\/j.ejphar.2026.178916_bib21","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/nu17111848","article-title":"Daily administration of agmatine reduced anxiety-like behaviors and neural responses in the brains of Male mice with persistent inflammation in the craniofacial region","volume":"17","author":"Iwamoto","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178916_bib22","first-page":"1","article-title":"Maryam izadi laybidi. melika izadi laybidi","volume":"l","author":"Izadi","year":"2023","journal-title":"J of Vac, Med &amp. Health Care"},{"key":"10.1016\/j.ejphar.2026.178916_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.physbeh.2015.12.015","article-title":"Spermidine ameliorates 3-nitropropionic acid (3-NP)-induced striatal toxicity: possible role of oxidative stress, neuroinflammation, and neurotransmitters","volume":"155","author":"Jamwal","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2026.178916_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102482","article-title":"Imidazoline receptors as a new therapeutic target in Huntington's disease: a preclinical overview","volume":"101","author":"Jari","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2026.178916_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.769184","article-title":"Molecular strategies to target protein aggregation in Huntington's disease","volume":"8","author":"Jarosinska","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178916_bib26","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00702-024-02750-w","article-title":"The pathobiology of depression in Huntington's disease: an unresolved puzzle","volume":"131","author":"Jellinger","year":"2024","journal-title":"J. Neural Transm."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178916_bib27","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.21037\/tp-22-476","article-title":"Sex-dependent effects of postweaning exposure to an enriched environment on visceral pain and anxiety-and depression-like behaviors induced by neonatal maternal separation","volume":"11","author":"Ji","year":"2022","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.ejphar.2026.178916_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pbb.2013.01.020","article-title":"Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage","volume":"105","author":"Jindal","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178916_bib29","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/biomedicines10061432","article-title":"Molecular pathophysiological mechanisms in Huntington's disease","volume":"10","author":"Jurcau","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.178916_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147045","article-title":"Agmatine modulates anxiety and depression-like behaviour in diabetic insulin-resistant rats","volume":"1747","author":"Kale","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2026.178916_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuro.2024.03.002","article-title":"Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced huntington's disease in rats","volume":"102","author":"Katariya","year":"2024","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178916_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5115\/acb.21.089","article-title":"Role of agmatine in the application of neural progenitor cell in central nervous system diseases: therapeutic potentials and effects","volume":"54","author":"Kosonen","year":"2021","journal-title":"Anatomy & Cell Biology"},{"key":"10.1016\/j.ejphar.2026.178916_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172976","article-title":"Agmatine reverses memory deficits induced by A\u03b21\u201342 peptide in mice: a key role of imidazoline receptors","volume":"196","author":"Kotagale","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2026.178916_bib34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuro.2019.05.001","article-title":"Neuroprotective offerings by agmatine","volume":"73","author":"Kotagale","year":"2019","journal-title":"Neurotoxicology"},{"issue":"5149","key":"10.1016\/j.ejphar.2026.178916_bib35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.7906055","article-title":"Agmatine: an endogenous clonidine-displacing substance in the brain","volume":"263","author":"Li","year":"1994","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178916_bib36","article-title":"Agmatine protects against zymosan\u2010induced acute lung injury in mice by inhibiting NF\u2010\u03baB\u2010mediated inflammatory response","volume":"2014","author":"Li","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178916_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/cdd.2009.22","article-title":"Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA-and ROS-dependent pathway","volume":"16","author":"Liot","year":"2009","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178916_bib38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pbb.2012.08.024","article-title":"Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy","volume":"103","author":"Machado","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2026.178916_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2478\/ebtj-2018-0016","article-title":"Inhibitory effects of agmatine on monoamine oxidase (MAO) activity: reconciling the discrepancies","volume":"2","author":"Mancinelli","year":"2018","journal-title":"EuroBiotech. J"},{"issue":"19","key":"10.1016\/j.ejphar.2026.178916_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.0000000000011888","article-title":"Prevalent nonmotor symptoms associated with huntington disease: challenging to interpret and with early impact on function","volume":"96","author":"McCusker","year":"2021","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ejphar.2026.178916_bib41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/mds.27787","article-title":"Insensitivity to loss predicts apathy in Huntington'S disease","volume":"34","author":"McLauchlan","year":"2019","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178916_bib42","doi-asserted-by":"crossref","first-page":"fcac278","DOI":"10.1093\/braincomms\/fcac278","article-title":"Different depression: motivational anhedonia governs antidepressant efficacy in Huntington's disease","volume":"4","author":"McLauchlan","year":"2022","journal-title":"Brain Communications"},{"key":"10.1016\/j.ejphar.2026.178916_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuropharm.2016.03.012","article-title":"The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: possible relevance for treatment-resistant depression","volume":"107","author":"Meylan","year":"2016","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.ejphar.2026.178916_bib44","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.3390\/ijms23073561","article-title":"Agmatine mitigates inflammation-related oxidative stress in BV-2 cells by inducing a pre-adaptive response","volume":"23","author":"Milosevic","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178916_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pbb.2018.08.005","article-title":"Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: comparison with ketamine and fluoxetine","volume":"173","author":"Neis","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"13","key":"10.1016\/j.ejphar.2026.178916_bib46","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.3390\/ijms26136220","article-title":"Update on the symptomatic treatment of huntington's disease: from pathophysiology to clinical practice","volume":"26","author":"Olmedo-Saura","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2026.178916_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0091-3057(01)00509-3","article-title":"Agmatine produces antinociception in tonic pain in mice","volume":"69","author":"Onal","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178916_bib48","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1080\/00207454.2023.2268262","article-title":"Possible involvement of GABAergic system on central amygdala mediated anxiolytic effect of agmatine in rats","volume":"134","author":"Paliwal","year":"2024","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178916_bib49","first-page":"9","article-title":"3-Nitropropionic acid and similar nitrotoxins","volume":"43","author":"Patocka","year":"2000","journal-title":"Metabolism of tryptophan in the liver: Interference with decarboxylation of other aromatic amino acids"},{"issue":"17\u201318","key":"10.1016\/j.ejphar.2026.178916_bib50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","article-title":"Agmatine: clinical applications after 100 years in translation","volume":"18","author":"Piletz","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.ejphar.2026.178916_bib51","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/appi.ajp.2008.08081201","article-title":"Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder","volume":"166","author":"Pizzagalli","year":"2009","journal-title":"Am. J. Psychiatr."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2026.178916_bib52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","article-title":"Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178916_bib53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","article-title":"Biological significance of agmatine, an endogenous ligand at imidazoline binding sites","volume":"133","author":"Raasch","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178916_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","article-title":"Is agmatine a novel neurotransmitter in brain?","volume":"21","author":"Reis","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178916_bib55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/bcpt.12604","article-title":"Agmatine reverses sub\u2010chronic stress induced nod\u2010like receptor protein 3 (NLRP 3) activation and cytokine response in rats","volume":"119","author":"Sahin","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.178916_bib56","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.pnpbp.2010.06.020","article-title":"Cytokines mediated inflammation and decreased neurogenesis in animal models of depression","volume":"35","author":"Song","year":"2011","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178916_bib57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/0269881111416686","article-title":"Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram","volume":"26","author":"Stoy","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178916_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/10253890.2018.1438405","article-title":"Exploratory rearing: a context-and stress-sensitive behaviour recorded in the open-field test","volume":"21","author":"Sturman","year":"2018","journal-title":"Stress"},{"issue":"6","key":"10.1016\/j.ejphar.2026.178916_bib59","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euroneuro.2013.12.002","article-title":"Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats","volume":"24","author":"Taksande","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2026.178916_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2010.03.058","article-title":"Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats","volume":"637","author":"Taksande","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178916_bib61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","article-title":"Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine","volume":"57","author":"Taksande","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.178916_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172779","article-title":"Agmatine reverses ethanol consumption in rats: evidences for an interaction with imidazoline receptors","volume":"186","author":"Taksande","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.ejphar.2026.178916_bib63","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.3390\/ijms25073845","article-title":"Huntington's disease: complex pathogenesis and therapeutic strategies","volume":"25","author":"Tong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178916_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14304","article-title":"Dysfunction of ventrolateral striatal dopamine receptor type 2-expressing medium spiny neurons impairs instrumental motivation","volume":"8","author":"Tsutsui-Kimura","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178916_bib65","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future","volume":"15","author":"Tunez","year":"2010","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ejphar.2026.178916_bib66","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s11064-024-04158-0","article-title":"Effect of capsaicin on 3-NP-induced neurotoxicity: a pre-clinical study","volume":"49","author":"Tyagi","year":"2024","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178916_bib67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17460441.2023.2201493","article-title":"Animal models of Huntington's disease and their applicability to novel drug discovery and development","volume":"18","author":"Upadhayay","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"issue":"11","key":"10.1016\/j.ejphar.2026.178916_bib68","doi-asserted-by":"crossref","first-page":"981","DOI":"10.5498\/wjp.v11.i11.981","article-title":"Agmatine as a novel candidate for rapid-onset antidepressant response","volume":"11","author":"Valverde","year":"2021","journal-title":"World J. Psychiatr."},{"issue":"10","key":"10.1016\/j.ejphar.2026.178916_bib69","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/ejn.12538","article-title":"Glucocorticoid receptor deletion from the dorsal raph\u00e9 nucleus of mice reduces dysphoria\u2010like behavior and impairs hypothalamic\u2010pituitary\u2010adrenocortical axis feedback inhibition","volume":"39","author":"Vincent","year":"2014","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.ejphar.2026.178916_bib70","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.5530\/ijper.55.4.204","article-title":"Ameliorative effects of 3-methyladenine and chloroquine in 3-nitropropionic-induced Huntington's disease like symptoms in mice","volume":"55","author":"Virdi","year":"2021","journal-title":"Indian J Pharm Educ Res"},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2026.178916_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2007.03.027","article-title":"Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test","volume":"565","author":"Zeidan","year":"2007","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:07:23Z","timestamp":1783184843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926003985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"alternative-id":["S0014299926003985"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178916","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine interaction with imidazoline receptor inhibits manifestation of depression-like behavior in 3-Nitropropionic acid-induced Huntington's disease-like phenotype in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178916"}}